Neurofilament Light Chain Levels Are Predictive of Clinical Conversion in Radiologically Isolated Syndrome
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received March 8, 2022
- Accepted in final form August 29, 2022
- First Published October 24, 2022.
Author Disclosures
- Manon Rival, MD*,
- Eric Thouvenot, MD, PhD*,
- Lucile Du Trieu de Terdonck, PhD,
- Sabine Laurent-Chabalier, PhD,
- Christophe Demattei, PhD,
- Ugur Uygunoglu, MD,
- Giovanni Castelnovo, MD,
- Mikael Cohen, MD, PhD,
- Darin T. Okuda, MD, PhD,
- Orhun H. Kantarci, MD, PhD,
- Daniel Pelletier, MD,
- Christina Azevedo, MD, PhD,
- Philippe Marin, PhD,
- Sylvain Lehmann, MD, PhD,
- Aksel Siva, MD, PhD,
- Thibault Mura, MD, PhD and
- Christine Lebrun-Frenay, MD, PhD
- on behalf of SFSEP and RISC
- Manon Rival, MD*,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Eric Thouvenot, MD, PhD*,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Lucile Du Trieu de Terdonck, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Sabine Laurent-Chabalier, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Christophe Demattei, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Ugur Uygunoglu, MD,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Giovanni Castelnovo, MD,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Mikael Cohen, MD, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Darin T. Okuda, MD, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Orhun H. Kantarci, MD, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Daniel Pelletier, MD,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Christina Azevedo, MD, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Philippe Marin, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Sylvain Lehmann, MD, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Aksel Siva, MD, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Thibault Mura, MD, PhD and
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Christine Lebrun-Frenay, MD, PhD
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (M.R., E.T., G.C.), Nîmes University Hospital Center, Univ. Montpellier; Functional Genomics Institute (M.R., E.T., L.D.T.T., P.M.), Univ. Montpellier, CNRS, INSERM; Department of Biostatistics (S.L.-C., C.D., T.M.), Clinical Epidemiology, Public Health and Innovation in Methdology (BESPIM), Nîmes University Hospital Center, Univ. Montpellier, France; Department of Neurology (U.U., A.S.), Cerrahpasa School of Medecine, University of Istanbul, Turkey; Centre de Ressources et Compétences Sclérose En Plaques (CRCSEP) (M.C., C.L.-F.), CHU de Nice, Hôpital Pasteur 2, Université Côte d’Azur, UR2CA-URRIS, France; UT Southwestern Medical Center (D.T.O.), Dallas, TX; Mayo Clinic (O.H.K.), Rochester, MN; University of South California (D.P., C.A.), Los Angeles; and LBPC-PPC (S.L.), Univ. Montpellier, CHU Montpellier, INM, INSERM, France.
- Correspondence
Prof. Thouvenot eric.thouvenot{at}chu-nimes.fr
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Daniel Friedman and Dr. Sharon Chiang
► Watch
Related Articles
- No related articles found.